CDNA - CIK 0001217234
The table below shows CareDx, Inc.'s cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Operating cash flow | $42.03M | $38.05M | -$18.39M | -$25.24M | -$19.29M | $33.43M |
| Capital expenditure | - | - | - | - | - | - |
| Investing cash flow | $2.16M | -$483.00K | $40.45M | -$228.50M | $47.71M | -$100.39M |
| Dividends paid | - | - | - | - | - | - |
CareDx, Inc. reported operating cash flow of $42.03M for fiscal year 2025. That is up 10.5% from $38.05M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow grew from -$16.52M (FY 2016) to $42.03M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Stock buybacks | $87.77M | $522.00K | $27.54M | $642.00K | $0.00 | $0.00 |
| Financing cash flow | -$93.39M | -$5.61M | -$29.61M | -$4.54M | $185.64M | $163.15M |